Putting The Pieces Together For Combo Products Oversight
Executive Summary
Bradley Thompson has been shepherding the Combination Products Coalition for more than a decade. In a recent interview, he said the recent policy spotlight on the combo-products space, including in a recent user-fee deal, is a welcome development after a period of neglect. He also spoke about the numerous reforms in the works and the state of the sector.
You may also be interested in...
Combo Product Safety: US FDA Rule On Postmarket Reporting Nears Finalization
Industry is eagerly awaiting guidance on combination products, and after seven years the postmarketing reg may be at top of the agency’s queue.
Mylan's EpiPen Nightmare Not Over Yet, But Will Congress Just Write?
Unless Republicans are convinced the market can't fix the problem, Mylan officials may only get congressional letters on the EpiPen price increase.
PDUFA First: Fees To Support Device Center Staff
To enhance combination product reviews, drug fee revenue will pay for related positions in CDRH.